Skip to content
OpenCapital
Collapse sidebar
Watchlist
Screener
Filings
Earnings
Charts
Collapse sidebar
Screener
Stocks
Vir Biotechnology, Inc.
Business Segments
Business Segments
Business Segments
11 metrics
Total revenues
Contract manufacturing
Personnel
Clinical costs
Licenses, collaborations and contingent consideration, net
Other R&D
SG&A
Restructuring, long-lived assets impairment and related charges, net
Plus: Other segment items
Net loss
Cost of revenue
Watchlist
Screener
Filings
Earnings
Charts